DpDNet: An Dual-Prompt-Driven Network for Universal PET-CT Segmentation

📅 2025-07-08
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
PET-CT lesion segmentation faces challenges including noise sensitivity, small and morphologically heterogeneous lesions, and interference from physiological high-metabolism regions; existing unified single-task approaches neglect cancer-type specificity. To address this, we propose DpDNet, a dual-prompt-driven network that jointly models cancer-specific and cross-cancer prompts to explicitly disentangle and integrate both unique and shared representations across cancer types. We introduce a prompt-aware decoding head to mitigate early-stage prompt-induced feature forgetting and adopt a dual-branch prompt architecture with end-to-end multi-task training. Evaluated on PET-CT data from four cancer types, DpDNet significantly outperforms state-of-the-art methods. Furthermore, it successfully transfers to breast cancer survival analysis, markedly improving risk stratification performance.

Technology Category

Application Category

📝 Abstract
PET-CT lesion segmentation is challenging due to noise sensitivity, small and variable lesion morphology, and interference from physiological high-metabolic signals. Current mainstream approaches follow the practice of one network solving the segmentation of multiple cancer lesions by treating all cancers as a single task. However, this overlooks the unique characteristics of different cancer types. Considering the specificity and similarity of different cancers in terms of metastatic patterns, organ preferences, and FDG uptake intensity, we propose DpDNet, a Dual-Prompt-Driven network that incorporates specific prompts to capture cancer-specific features and common prompts to retain shared knowledge. Additionally, to mitigate information forgetting caused by the early introduction of prompts, prompt-aware heads are employed after the decoder to adaptively handle multiple segmentation tasks. Experiments on a PET-CT dataset with four cancer types show that DpDNet outperforms state-of-the-art models. Finally, based on the segmentation results, we calculated MTV, TLG, and SUVmax for breast cancer survival analysis. The results suggest that DpDNet has the potential to serve as a valuable tool for personalized risk stratification, supporting clinicians in optimizing treatment strategies and improving outcomes. Code is available at https://github.com/XinglongLiang08/DpDNet.
Problem

Research questions and friction points this paper is trying to address.

Addresses PET-CT lesion segmentation challenges like noise and small lesions
Overcomes limitations of treating all cancers as a single task
Enables personalized risk stratification via improved segmentation accuracy
Innovation

Methods, ideas, or system contributions that make the work stand out.

Dual-Prompt-Driven network for cancer segmentation
Prompt-aware heads to handle multiple tasks
Adaptive prompts for specific and shared features
🔎 Similar Papers
No similar papers found.
X
Xinglong Liang
Department of Radiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Geert Grooteplein 10, 6525 GA, Nijmegen, The Netherlands
J
Jiaju Huang
Faculty of Applied Sciences, Macao Polytechnic University, 999078, Macao Special Administrative Region of China
Luyi Han
Luyi Han
Radboud University Medical Center, Netherlands Cancer Institute
Medical Image Analysis
T
Tianyu Zhang
Department of Radiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Geert Grooteplein 10, 6525 GA, Nijmegen, The Netherlands
X
Xin Wang
Department of Radiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, P. Debyelaan 25, 6202 AZ, Maastricht, The Netherlands
Y
Yuan Gao
Department of Radiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, P. Debyelaan 25, 6202 AZ, Maastricht, The Netherlands
C
Chunyao Lu
Department of Radiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Geert Grooteplein 10, 6525 GA, Nijmegen, The Netherlands
L
Lishan Cai
Department of Radiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, P. Debyelaan 25, 6202 AZ, Maastricht, The Netherlands
Tao Tan
Tao Tan
FCA MPU
Medical Imaging AI
Ritse Mann
Ritse Mann
Breast and Interventional Radiologist, Radboudumc
radiologie